Carlie Irsay-Gordon is younger than her peers, with her own distinctive vision of how an NFL owner can lead. It is about to ...

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

Some agencies have put new conditions on granting telework as a reasonable accommodation for federal employees with ...

In The Star's annual year in review, many of the county's biggest news stories of 2025 stemmed from decisions in Washington, ...

As the war grinds on, sophisticated Russian defenses have pushed Ukraine to develop a frightening new weapon: semiautonomous killing machines.

Uncertainty is increasingly complicating economic forecasts, but all eyes are on Trump, Ukraine, and AI. Europe’s future ...

By supporting CCBHCs, the state creates more effective and sustainable pathways for individuals to access behavioral health ...

Newron's partner EA Pharma Co., Ltd. announces today the initiation of its Phase III clinical trial with evenamide in Japan.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 8 minutes I ...

How geopolitics and sanctions may impact oil pricing in the year ahead. Whether the "energy transition" is still moving ...

NPC is an ultra-rare, relentlessly progressive, genetic disorder that leads to premature mortality. MIPLYFFA, used in conjunction with miglustat, is the only treatment shown to halt disease ...